Close Menu

NEW YORK (GenomeWeb) – ID Genomics said today that it has formed a national consortium of clinical partners with the objective of improving the speed and accuracy of infectious disease diagnostics and antibiotic treatment.

The firm will work with partners in the consortium to record genetic fingerprints of antibiotic strains isolated from patients with active infections, and to characterize the strains' antibiotic susceptibility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.